Kukje Pharma Co Ltd (002720) — Cash Flow-to-Debt Ratio
Kukje Pharma Co Ltd (002720) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of ₩4.99 Billion could theoretically repay 0% of its total liabilities (₩84.80 Billion) in one year. See Kukje Pharma Co Ltd (002720) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kukje Pharma Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Kukje Pharma Co Ltd across 14 annual periods. Also explore Kukje Pharma Co Ltd (002720) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Kukje Pharma Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Kukje Pharma Co Ltd. For market capitalisation and broader financial context, see 002720 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | ₩3.94 Billion | ₩76.00 Billion | ▲ +13.6% |
| 2023 | 0.05x | ₩3.58 Billion | ₩78.31 Billion | ▼ -56.1% |
| 2022 | 0.10x | ₩6.50 Billion | ₩62.51 Billion | ▼ -22.8% |
| 2021 | 0.13x | ₩9.60 Billion | ₩71.20 Billion | ▲ +98.6% |
| 2020 | 0.07x | ₩5.10 Billion | ₩75.13 Billion | ▲ +38.7% |
| 2019 | 0.05x | ₩3.60 Billion | ₩73.64 Billion | ▼ -78.7% |
| 2018 | 0.23x | ₩13.25 Billion | ₩57.54 Billion | ▲ +1770.8% |
| 2017 | 0.01x | ₩786.10 Million | ₩63.87 Billion | ▼ -95.3% |
| 2016 | 0.26x | ₩16.10 Billion | ₩61.94 Billion | ▲ +448.9% |
| 2015 | -0.07x | ₩-5.08 Billion | ₩68.18 Billion | ▼ -8026.7% |
| 2014 | 0.00x | ₩-61.11 Million | ₩66.66 Billion | ▲ +98.8% |
| 2013 | -0.08x | ₩-4.60 Billion | ₩59.10 Billion | ▼ -393.2% |
| 2012 | 0.03x | ₩1.58 Billion | ₩59.57 Billion | ▼ -89.8% |
| 2011 | 0.26x | ₩17.39 Billion | ₩66.82 Billion | — |